Prener Anne bought KROS
July 1, 2026 · Form 4 insider transaction
Prener Anne bought 13,786 shares of Keros Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
13,786
Price
$0.00
Total value
N/A
InsiderPrener Anne
RoleDirector
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateJuly 1, 2026
Filing dateJuly 6, 2026
Shares owned after13,786
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a restricted stock unit ("RSU") award. The RSUs shall vest over a three-year period in twelve equal quarterly installments with the first such vesting to occur on August 15, 2026, subject to the Reporting Person's continuous service through each such vesting date.